The new unified international diabetes federation/American heart association/ national heart, lung, and blood institute metabolic syndrome definition: Does it correlate better with c-reactive protein in Chinese patients diagnosed with type 2 diabetes?

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 1923-1932

  Lu, B ^a,b   Zhang, S ^a,b   Wen, J ^a,b   Yang, Y ^a,b   Yang, Z ^a,b   Zhang, Z ^a,b   Wang, X ^a,b   Hu, R ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

C reactive protein; Idf aha nhlbi definition; Metabolic syndrome; References; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 78650851671     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800605     Document Type: Article

References (26)

1. Hu G, Qiao Q, Tuomilehto J, et al: Prevalence of the metabolic syndrome and its relation to all- cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-1076.
2. Girman CJ, Rhodes T, Mercuri M, et al: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93: 136-141.
3. Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle- aged men. JAMA 2002; 288: 2709-2716.
4. Malik S, Wong ND, Franklin SS, et al: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
5. Pickup JC, Mattock MB, Chusney GD, et al: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
6. Pradhan AD, Manson JE, Rifai N, et al: Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
7. Tracy RP, Kuller LH: C-reactive protein, heart disease risk, and the popular media. Arch Intern Med 2005; 165: 2058-2060.
8. Onat A, Can G, Hergenç G: Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008; 57: 207-214.
9. Alberti KG, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus Group: The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
10. Alberti KG, Eckel RH, Grundy SM, et al: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
11. de Simone G, Devereux RB, Chinali M, et al on behalf of the Strong Heart Study Investigators: Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 2007; 30: 1851-1856.
12. Luk AO, Ma RC, So WY, et al: The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify type 2 diabetic patients at increased risk of chronic kidney disease. Diabet Med 2008; 25: 1419-1425.
13. Lu B, Yang Y, Song X, et al: An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 2006; 55: 1088-1096.
14. Lu B, Wen J, Song XY, et al: High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2007; 75: 184-192.
15. Lu B, Song X, Dong X, et al: High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications 2008; 22: 96-103.
16. Dong X, He M, Song X, et al: Performance and comparison of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese type 2 diabetic population. Diabet Med 2007; 24: 1482-1486.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
18. Ye X, Yu Z, Li H, et al: Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007; 49: 1798-1805.
19. Lao XQ, Thomas GN, Jiang CQ, et al: C-reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study. Atherosclerosis 2007; 194: 483-489.
20. Wen J, Liang Y, Wang F, et al: Association of C- reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 2009; 42: 976-983.
21. Esposito K, Giugliano D: The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004; 14: 228-232.
22. Ritchie SA, Connell JM: The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007;17: 319-326.
23. Hoekstra T, Geleijnse JM, Schouten EG, et al: Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis 2005; 15: 270-278.
24. Rutter MK, Meigs JB, Sullivan LM, et al: C- reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385.
25. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
26. Park HS, Park JY, Yu R: Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract 2005; 69: 29-35.